Ceritinib/ceritinib manufacturer and drug source information

Ceritinib (Ceritinib, also known as ceritinib) is an oralALK (anaplastic lymphoma kinase) inhibitor, mainly used for treatmentALKpositive non-small cell lung cancer (NSCLC) patients are especially suitable for patients who are resistant or intolerant to crizotinib (Crizotinib). The drug achieves anti-tumor effects by selectively inhibiting ALK tyrosine kinase, blocking downstream signaling pathways, inhibiting tumor cell proliferation and promoting apoptosis. Its listing provides a more effective second-line treatment option for patients with ALK positive lung cancer.

Seritinib was originally developed and produced by Novartis Pharmaceuticals (Novartis Pharmaceuticals), which has conducted multi-center clinical trials around the world to verify the efficacy and safety of the drug. The original drug has been launched in the United States, Japan, Europe and other places, and has been approved by the corresponding drug regulatory agencies. Novartis' production and quality management of Ceritinib strictly follows GMP standards to ensure stable drug ingredients and reliable efficacy.

In the domestic market, ceritinib has also been launched, but as it is an imported anti-tumor targeted drug, its acquisition mainly relies on hospital pharmacies or designated purchasing channels. When patients purchase drugs in China, they should give priority to original drugs from regular hospitals or pharmacies to ensure that the drugs are of legal origin and of reliable quality. In addition, some regions may provide the drug through cross-border or overseas channels, but national drug management regulations must be strictly followed to avoid the risk of counterfeit or low-quality drugs.

Generally speaking, the production and supply of ceritinib are mainly based on Novartis’ original drugs, which are from reliable sources and have undergone strict clinical verification. Domestic patients can obtain drugs through regular hospital pharmacies and authorized channels. Original drugs are also available in overseas markets, but at higher prices. Patients should consult a professional doctor before use to understand the source, dosage and usage of the drug to ensure the safety and efficacy of the treatment while avoiding potential risks caused by illegal channels.

Reference materials:https://www.drugs.com